Characterization of a novel model for atherosclerosis imaging: the apolipoprotein E-deficient rat.

Autor: Sijbesma JWA; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands. j.w.a.sijbesma@umcg.nl., van Waarde A; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands., Kristensen S; Department of Electrical and Computer Engineering, Aarhus University, Aarhus, Denmark., Kion I; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands., Tietge UJF; Division of Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.; Clinical Chemistry, Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden., Hillebrands JL; Division of Pathology, Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Bulthuis MLC; Division of Pathology, Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Buikema H; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Nakladal D; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Comenius University Science Park, Bratislava, Slovakia.; 5th Department of Internal Medicine, Faculty of Medicine, Comenius University Bratislava, Bratislava, Slovakia., Westerterp M; Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Liu F; Division of Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Boersma HH; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Dierckx RAJO; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands., Slart RHJA; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.; Faculty of Science and Technology, Department of Biomedical Photonic Imaging, University of Twente, Enschede, The Netherlands.

Publikováno v: EJNMMI research [EJNMMI Res] 2023 Dec 11; Vol. 13 (1), pp. 106. Date of Electronic Publication: 2023 Dec 11.

Calciprotein Particles Induce Endothelial Dysfunction by Impairing Endothelial Nitric Oxide Metabolism.

Autor: Feenstra L; Department of Pathology and Medical Biology (L.F., G.K., J.-L.H.), University of Groningen, University Medical Center Groningen, The Netherlands., Kutikhin AG; Laboratory for Molecular, Translational and Digital Medicine, Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russian Federation (A.G.K., D.K.S.)., Shishkova DK; Laboratory for Molecular, Translational and Digital Medicine, Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russian Federation (A.G.K., D.K.S.)., Buikema H; Department of Clinical Pharmacy and Pharmacology (H.B., G.K.), University of Groningen, University Medical Center Groningen, The Netherlands., Zeper LW; Department of Physiology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands (L.W.Z.)., Bourgonje AR; Department of Gastroenterology and Hepatology (A.R.B.), University of Groningen, University Medical Center Groningen, The Netherlands., Krenning G; Department of Pathology and Medical Biology (L.F., G.K., J.-L.H.), University of Groningen, University Medical Center Groningen, The Netherlands.; Department of Clinical Pharmacy and Pharmacology (H.B., G.K.), University of Groningen, University Medical Center Groningen, The Netherlands., Hillebrands JL; Department of Pathology and Medical Biology (L.F., G.K., J.-L.H.), University of Groningen, University Medical Center Groningen, The Netherlands.

Publikováno v: Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2023 Mar; Vol. 43 (3), pp. 443-455. Date of Electronic Publication: 2023 Feb 02.

Disruption of endothelial caveolae is associated with impairment of both NO- as well as EDHF in acetylcholine-induced relaxation depending on their relative contribution in different vascular beds

Autor: Xu, Y., Henning, R.H., van der Want, J.J.L., van Buiten, A., van Gilst, W.H., Buikema, H.

Publikováno v: In Life Sciences 2007 80(18):1678-1685

Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study.

Autor: Acs B; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA. balazs.acs@ki.se.; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden. balazs.acs@ki.se.; Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden. balazs.acs@ki.se., Leung SCY; University of British Columbia, Vancouver, BC, Canada., Kidwell KM; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, USA., Arun I; Tata Medical Center, Kolkata, West Bengal, India., Augulis R; Vilnius University Faculty of Medicine and National Center of Pathology, Vilnius University Hospital Santaros Clinics, Vilnius, Lithuania., Badve SS; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA., Bai Y; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA., Bane AL; Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, ON, Canada., Bartlett JMS; Ontario Institute for Cancer Research, Toronto, ON, Canada.; Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom., Bayani J; Ontario Institute for Cancer Research, Toronto, ON, Canada., Bigras G; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada., Blank A; Institute of Pathology, University of Bern, Bern, Switzerland.; Institute of Pathology, Triemli Hospital Zurich, Zurich, Switzerland., Buikema H; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Chang MC; Department of Pathology & Laboratory Medicine, University of Vermont Medical Center, Burlington, VT, USA., Dietz RL; Department of Pathology, Olive View-UCLA Medical Center, Los Angeles, CA, USA., Dodson A; UK NEQAS for Immunocytochemistry and In-Situ Hybridisation, London, United Kingdom., Fineberg S; Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, NY, USA., Focke CM; Dietrich-Bonhoeffer Medical Center, Neubrandenburg, Mecklenburg-Vorpommern, Germany., Gao D; University of British Columbia, Vancouver, BC, Canada., Gown AM; PhenoPath Laboratories, Seattle, WA, USA., Gutierrez C; Lester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA., Hartman J; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden., Kos Z; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada., Lænkholm AV; Department of Surgical Pathology, Zealand University Hospital, Roskilde, Denmark., Laurinavicius A; Vilnius University Faculty of Medicine and National Center of Pathology, Vilnius University Hospital Santaros Clinics, Vilnius, Lithuania., Levenson RM; Department of Medical Pathology and Laboratory Medicine, University of California Davis Medical Center, Sacramento, CA, USA., Mahboubi-Ardakani R; Department of Medical Pathology and Laboratory Medicine, University of California Davis Medical Center, Sacramento, CA, USA., Mastropasqua MG; European Institute of Oncology, Milan, Italy., Nofech-Mozes S; University of Toronto Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Osborne CK; Lester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA., Penault-Llorca FM; Imagerie Moléculaire et Stratégies Théranostiques, UMR1240, Université Clermont Auvergne, INSERM, Clermont-Ferrand, France.; Service de Pathologie, Centre Jean PERRIN, Clermont-Ferrand, France., Piper T; Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom., Quintayo MA; Ontario Institute for Cancer Research, Toronto, ON, Canada., Rau TT; Institute of Pathology, University of Bern, Bern, Switzerland.; Institute of Pathology, Heinrich Heine University and University Hospital of Duesseldorf, Duesseldorf, Germany., Reinhard S; Institute of Pathology, University of Bern, Bern, Switzerland., Robertson S; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden., Salgado R; Department of Pathology, GZA-ZNA, Antwerp, Belgium.; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia., Sugie T; Kansai Medical University, Hirakata, Osaka, Japan., van der Vegt B; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Viale G; European Institute of Oncology, Milan, Italy.; European Institute of Oncology IRCCS, and University of Milan, Milan, Italy., Zabaglo LA; The Institute of Cancer Research, London, United Kingdom., Hayes DF; University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA., Dowsett M; The Institute of Cancer Research, London, United Kingdom., Nielsen TO; University of British Columbia, Vancouver, BC, Canada., Rimm DL; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA. david.rimm@yale.edu.

Publikováno v: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2022 Oct; Vol. 35 (10), pp. 1362-1369. Date of Electronic Publication: 2022 Jun 21.

The (R)-enantiomer of the 6-chromanol derivate SUL-121 improves renal graft perfusion via antagonism of the α-adrenoceptor

Autor: Nakladal, D., Buikema, H., Romero, A. Reyes, Lambooy, S. P. H., Bouma, J., Krenning, G., Vogelaar, P., van der Graaf, A. C., Groves, M. R., Kyselovic, J., Henning, R. H., Deelman, L. E.

Publikováno v: Scientific Reports, 9(1):13. Nature Publishing Group

SUL-compounds are protectants from cold-induced ischemia and mitochondrial dysfunction. We discovered that adding SUL-121 to renal grafts during warm machine reperfusion elicits a rapid improvement in perfusion parameters. Therefore, we investigate t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::eb6596a5889c576b04f7caa18a94e2a4
https://research.rug.nl/en/publications/7b6d0c7e-7ed4-4d30-929a-092af4e32af3